ARCHIVES

Two Phase III Ramucirumab Trials Both Deliver Improved Overall and Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

XGEVA not Inferior to Zometa In 1,776-Patient Phase III Study

March 25, 2011

ECOG Phase III Trial To Test Hormones Vs. Chemotherapy For Prostate Cancer.

July 4, 2003

After Furlough, Blizzard, NCI Struggles to Clear Backlog and Resume Business

January 19, 1996

CCOP RFA On The Street; Addition Of Cancer Control Research Adds New Dimension To Program

July 18, 1986